Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS
Contenuto archiviato il 2024-05-14

Mammalian cloning in Europe: prospects and public policy

Obiettivo



This study is designed to provide an assessment of mammalian cloning technology, its possible risks and benefits, and how public policy might help steer its development in a manner which is both socially acceptable and economically useful.
The creation of the first cloned mammal, 'Dolly' the sheep, has been seen as a landmark, demonstrating both the power of science and the scale of public fears surrounding genetic engineering. This technical achievement has provoked controversy and stimulated major public policy debates in many countries, with the emphasis on the ethics of cloning humans. However, fear of human cloning has overshadowed the longer-term significance of this research, as it is in the field of animal biotechnology and in the development of new medical technologies that cloning could provide major benefits.
Public policy makers are therefore faced with a dilemma in balancing the need to maintain public confidence in biotechnology, by guaranteeing that research on cloning is ethical and socially acceptable, whilst at the same time ensuring that regulation will not inhibit its industrial exploitation.
The objectives of the study are therefore to:
1. Assess the scientific significance of the cloning of mammals and identify both short and long-term potential applications of the technique; 2. Make a comparative analysis of the public perception of mammalian cloning, the ethical problems raised, and the public policy response to these issues, in the UK and the Netherlands;
3. Analyse the relative success of different national approaches to mammalian cloning and suggest how public policy might be best used to socially manage the technology in Europe.
To meet these objectives the work programme will be composed of the following activities:
- A detailed literature review of research on mammalian cloning - Interviews with leading scientists and companies working on mammalian cloning.
- A short survey of European biotechnology firms working in fields related to cloning
- Detailed case studies of the public debate and regulation of cloning in the UK and Netherlands
The project will conclude by making an informed assessment of 1. the prospects, near-term applications and potential benefits of cloning; 2. the key ethical and social issues these developments are likely to raise; and 3. the strengths and weaknesses of different public policy approaches to this issue. Recommendations will be made for how policy in Europe might be improved to ensure that technologies based on mammalian cloning techniques might be effectively developed in a socially acceptable manner.

Campo scientifico (EuroSciVoc)

CORDIS classifica i progetti con EuroSciVoc, una tassonomia multilingue dei campi scientifici, attraverso un processo semi-automatico basato su tecniche NLP. Cfr.: Il Vocabolario Scientifico Europeo.

È necessario effettuare l’accesso o registrarsi per utilizzare questa funzione

Programma(i)

Programmi di finanziamento pluriennali che definiscono le priorità dell’UE in materia di ricerca e innovazione.

Argomento(i)

Gli inviti a presentare proposte sono suddivisi per argomenti. Un argomento definisce un’area o un tema specifico per il quale i candidati possono presentare proposte. La descrizione di un argomento comprende il suo ambito specifico e l’impatto previsto del progetto finanziato.

Invito a presentare proposte

Procedura per invitare i candidati a presentare proposte di progetti, con l’obiettivo di ricevere finanziamenti dall’UE.

Dati non disponibili

Meccanismo di finanziamento

Meccanismo di finanziamento (o «Tipo di azione») all’interno di un programma con caratteristiche comuni. Specifica: l’ambito di ciò che viene finanziato; il tasso di rimborso; i criteri di valutazione specifici per qualificarsi per il finanziamento; l’uso di forme semplificate di costi come gli importi forfettari.

CSC - Cost-sharing contracts

Coordinatore

UNIVERSITY OF SUSSEX
Contributo UE
Nessun dato
Costo totale

I costi totali sostenuti dall’organizzazione per partecipare al progetto, compresi i costi diretti e indiretti. Questo importo è un sottoinsieme del bilancio complessivo del progetto.

Nessun dato

Partecipanti (1)

Il mio fascicolo 0 0